A cell-permeable ACL inhibitor (IC50 = 0.13 μM) that has been reported to reduce weight gain and lower plasma cholesterol, triglycerides, and glucose in a mouse model of hyperlipidemia
Size
25 mg
Concentration
n/a
Applications
n/a
Other Names
cell-permeable inhibitor inhibition ACL hyperlipidemia ATP citrate lyase acetyl-CoA lipogenesis cancer metabolism reduce weight gain plasma cholesterol triglycerides glucose BMS303141